[8] [8] LUO T, LU Y, YAN S, et al. Network pharmacology in research of Chinese medicine formula: methodology, application and prospective ［J］. Chinese Journal of Integrative Medicine, 2019, 26(1): 72-80.

[9] [9] SAIKIA S, BORDOLOI M. Molecular docking: challenges, advances and its use in drug discovery perspective ［J］. Current Drug Targets, 2019, 20(5): 501-521.

[10] [10] RU J, LI P, WANG J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines ［J］. Journal of Cheminformatics, 2014, 16(6): 13.

[11] [11] LIU W, FAN Y, TIAN C, et al. Deciphering the molecular targets and mechanisms of HGWD in the treatment of rheumatoid arthritis via network pharmacology and molecular docking［J］. Evidence-based Complementary and Alternative Medicine, 2020, 26: 7151634.

[17] [17] LIU S, TIAN L, CHAI G, et al. Targeting heme oxygenase-1 by quercetin ameliorates alcohol-induced acute liver injury via inhibiting NLRP3 inflammasome activation ［J］. Food & Function, 2018, 9(8): 4184-4193.

[19] [19] CHEN Z, WU A, JIN H, et al. β-Sitosterol attenuates liver injury in a rat model of chronic alcohol intake ［J］. Archives of Pharmacal Research, 2020, 43(11): 1197-1206.

[22] [22] XIONG J, WANG C, CHEN H, et al. Aβ-induced microglial cell activation is inhibited by baicalin through the JAK2/STAT3 signaling pathway ［J］. International Journal of Neuroscience, 2014, 124(8): 609-620.

[23] [23] XU Z, XU M, LIU P, et al. The mTORC2-Akt1 cascade is crucial for c-Myc to promote hepatocarcinogenesis in mice and humans［J］. Hepatology, 2019, 70(5): 1600-1613.

[24] [24] KOU K, CHEN Y, ZHOU J, et al. Hepatic epithelioid hemangioendothelioma: update on diagnosis and therapy ［J］. World Journal of Clinical Cases, 2020, 8(18): 3978-3987.

[25] [25] MELINCOVICI C S, BOSCA A B, ?U?MAN S, et al. Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis ［J］. Romanian Journal of Morphology and Embryology, 2018, 59(2): 455-467.

[26] [26] TELLI T A, OKTEN I N, TUYLU T B, et al. VEGF-VEGFR pathway seems to be the best target in hepatic epithelioid hemangioendothelioma: a case series with review of the literature ［J］. Current Problems in Cancer, 2020, 44(5):100568.

[27] [27] ZHENG L,WEN X, DAI Y. Mechanism of Jianpi Qingchang Huashi Recipe in treating ulcerative colitis: a study based on network pharmacology and molecular docking ［J］. World Journal of Clinical Cases, 2021, 9(26): 7653-7670.

[28] [28] LEON M, CHAVEZ L, SURANI S. Hepatic hemangioma: what internists need to know ［J］. World Journal of Gastroenterology, 2020, 26(1): 11-20.

[29] [29] ZHAO J, QI Y, YU Y. STAT3: a key regulator in liver fibrosis ［J］. Annals of Hepatology, 2021, 21: 100224.

[30] [30] WALLACE S J, TACKE F, SCHWABE R F, et al. Understanding the cellular interactome of non-alcoholic fatty liver disease ［J］. JHEP Reports : Innovation in Hepatology, 2022, 4(8): 100524.

[32] [32] FANG Y, YAN D, WANG L, et al. Circulating microRNAs (miR-16, miR-22, miR-122) expression and early diagnosis of hepatocellular carcinoma ［J］. Journal of Clinical Laboratory Analysis, 2022, 36(7): e24541.

[33] [33] KASSOUF T, SUMARA G. Impact of conventional and atypical MAPKs on the development of metabolic diseases［J］. Biomolecules, 2020, 10(9): 1256.